Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nafiseh Izadi"'
Autor:
Shadi Parsa, Saman Soleimanpour, Mohammad Derakhshan, Leila Babaei Nik, Raha Mir, Nafiseh Izadi
Publikováno v:
Iranian Journal of Medical Microbiology, Vol 14, Iss 2, Pp 108-124 (2020)
Tuberculosis is one of the most dangerous infectious diseases in the world and causes nearly two million deaths each year, especially in developing countries. Meanwhile, multidrug resistance tuberculosis (MDR-TB) is due to the resistance of Mycobacte
Externí odkaz:
https://doaj.org/article/754045f3be6f41439a425b826aeaef8e
Publikováno v:
Iranian Journal of Pathology, Vol 12, Iss 4, Pp 377-383 (2017)
Background and Objectives: Since the fluoroquinolones are the broad-spectrum antibiotics, they affect both Gram-negative and Gram-positive bacteria. These antibiotics are widely prescribed by physicians. As a result, some bacteria, especially Enterob
Externí odkaz:
https://doaj.org/article/89bc35793d2d4408b89cd42c86dd643d
Publikováno v:
Respiratory Medicine Case Reports, Vol 15, Iss C, Pp 12-13 (2015)
We report a 69-years-old Iranian HIV negative male patient, with long-standing pulmonary tuberculosis (eleven years) co-infected with non-tuberculosis mycobacteria. Despite of initiation of first line anti-tuberculosis therapy after diagnosis the pat
Externí odkaz:
https://doaj.org/article/ffac1016b73e4d4ab9f299564d033a07
Autor:
Nafiseh Izadi, Leila Babaei Nik, Mohammad H. Derakhshan, Raha Mir, Shadi Parsa, Saman Soleimanpour
Publikováno v:
Iranian Journal of Medical Microbiology, Vol 14, Iss 2, Pp 108-124 (2020)
Tuberculosis is one of the most dangerous infectious diseases in the world and causes nearly two million deaths each year, especially in developing countries. Meanwhile, multidrug resistance tuberculosis (MDR-TB) is due to the resistance of Mycobacte
Autor:
Shadi Parsa, Atieh Yaghoubi, Nafiseh Izadi, Faezeh Sabet, Leila babaei Nik, Mohammad Derakhshan, Seyed Abdolrahim Rezaee, Zahra Meshkat, Seyed Javad Hoseini, Saeid Amel Jmehdar, Fatemeh Kiani, Amin Samiei, Saman Soleimanpour
Publikováno v:
Current microbiology. 79(9)
The effective management of multidrug-resistant tuberculosis (MDR-TB) and the need for rapid and accurate screening of rifampin (RIF) and isoniazid (INH)-resistant Mycobacterium tuberculosis (Mtb) isolates are the most fundamental and difficult chall
Publikováno v:
Iranian Journal of Pathology
Iranian Journal of Pathology, Vol 12, Iss 4, Pp 377-383 (2017)
Iranian Journal of Pathology, Vol 12, Iss 4, Pp 377-383 (2017)
Background and objectives Since the fluoroquinolones are the broad-spectrum antibiotics, they affect both Gram-negative and Gram-positive bacteria. These antibiotics are widely prescribed by physicians. As a result, some bacteria, especially Enteroba
Publikováno v:
Gene Reports. 21:100811
Oral cavity is considered as a heterogeneous habitat which is appropriate for various characteristic microbial community. One of the main innate defense mechanisms for maintaining oral health and controlling oral infections is the secretion of antimi
Autor:
Rongxing Lu, Nafiseh Izadi Yekta
Publikováno v:
ICC
Internet of things (IoT) has attracted significant attention in recent years, and various IoT devices including industrial and utility components and other items embedded with electronics, sensors, and network connectivity have already provided rich
Autor:
Mahboubeh Naderi Nasab, Saeid Amel Jamehdar, Zahra Meshkat, Maryam Rezaei, Elnaz Harifi Mood, Nafiseh Izadi
Publikováno v:
Jundishapur Journal of Microbiology
Background: Escherichia coli is an important bacterial species based on incidence and associated infection severity. Some E. coli strains produce extended-spectrum beta lactamase (ESBL) and are called ESBL-producing E. coli. These strains are resista
Publikováno v:
Respiratory Medicine Case Reports, Vol 15, Iss C, Pp 12-13 (2015)
Respiratory Medicine Case Reports
Respiratory Medicine Case Reports
We report a 69-years-old Iranian HIV negative male patient, with long-standing pulmonary tuberculosis (eleven years) co-infected with non-tuberculosis mycobacteria. Despite of initiation of first line anti-tuberculosis therapy after diagnosis the pat